Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide. Currently, most NAFLD prediction models are diagnostic models based on cross-sectional data, which failed to provide early identification or clarify causal relationships. We aimed to use time-series deep learning models with longitudinal health checkup records to predict the onset of NAFLD in the future, and update the model stepwise by incorporating new checkup records to achieve dynamic prediction. Methods: 10,493 participants with over 6 health checkup records from Beijing MJ Health Screening Center were included to conduct a retrospective cohort study, in which the constantly updated initial 5 checkup data were incorporated stepwise...
BackgroundPrevention and treatment of liver fibrosis at an early stage is of great prognostic import...
BackgroundPrevention and treatment of liver fibrosis at an early stage is of great prognostic import...
Although medical checkup data would be useful for identifying unknown factors of disease progression...
Background. Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver disease...
Some occasional drinkers develop Nonalcoholic Fatty Liver Disease (NAFLD). Hepatocytes are the key i...
Background and Aims: There is a high unmet need to develop noninvasive tools to identify nonalcoholi...
Background Non-alcoholic fatty liver disease (NAFLD) is highly prevalent and causes serious health c...
Background & aimsCurrent non-invasive scores for the assessment of severity of non-alcoholic fatty l...
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is t...
BackgroundNon-alcoholic fatty liver disease (NAFLD) is highly prevalent and causes serious health co...
BackgroundNon-alcoholic fatty liver disease (NAFLD) is highly prevalent and causes serious health co...
The prediction of the liver failure (LF) and its proper diagnosis would lead to a reduction in the c...
Non-alcoholic fatty liver disease (NAFLD) is the most global frequent liver disease, with a prevalen...
Background & Aims: Detecting non-alcoholic steatohepatitis (NASH) remains challenging, while at-ris...
Background & aims Current non-invasive scores for the assessment of severity of non-alcoholic fatty ...
BackgroundPrevention and treatment of liver fibrosis at an early stage is of great prognostic import...
BackgroundPrevention and treatment of liver fibrosis at an early stage is of great prognostic import...
Although medical checkup data would be useful for identifying unknown factors of disease progression...
Background. Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver disease...
Some occasional drinkers develop Nonalcoholic Fatty Liver Disease (NAFLD). Hepatocytes are the key i...
Background and Aims: There is a high unmet need to develop noninvasive tools to identify nonalcoholi...
Background Non-alcoholic fatty liver disease (NAFLD) is highly prevalent and causes serious health c...
Background & aimsCurrent non-invasive scores for the assessment of severity of non-alcoholic fatty l...
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is t...
BackgroundNon-alcoholic fatty liver disease (NAFLD) is highly prevalent and causes serious health co...
BackgroundNon-alcoholic fatty liver disease (NAFLD) is highly prevalent and causes serious health co...
The prediction of the liver failure (LF) and its proper diagnosis would lead to a reduction in the c...
Non-alcoholic fatty liver disease (NAFLD) is the most global frequent liver disease, with a prevalen...
Background & Aims: Detecting non-alcoholic steatohepatitis (NASH) remains challenging, while at-ris...
Background & aims Current non-invasive scores for the assessment of severity of non-alcoholic fatty ...
BackgroundPrevention and treatment of liver fibrosis at an early stage is of great prognostic import...
BackgroundPrevention and treatment of liver fibrosis at an early stage is of great prognostic import...
Although medical checkup data would be useful for identifying unknown factors of disease progression...